Home
/
CervoMed Inc.
/
Financials
/
Quarterly
CervoMed Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that CervoMed Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$322.6K
Nov 7, 2025
Q2
2025
Jun 30, 2025
$1.76M
Aug 8, 2025
Q1
2025
Mar 31, 2025
$1.92M
May 12, 2025
Q3
2025
Sep 30, 2024
$1.94M
Nov 7, 2025
Q2
2025
Jun 30, 2024
$3.29M
Aug 8, 2025
Q1
2025
Mar 31, 2024
$2.35M
May 12, 2025
Q3
2024
Sep 30, 2023
$1.53M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$1.72M
Aug 9, 2024
Q1
2024
Mar 31, 2023
$1.41M
May 14, 2024
Q3
2023
Sep 30, 2022
$0
Nov 13, 2023
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2014
Mar 31, 2014
$0
May 20, 2014
Q3
2013
Sep 30, 2013
$0
Nov 19, 2013
Q2
2013
Jun 30, 2013
$71.7K
Aug 14, 2013
Q1
2013
Mar 31, 2013
$71.7K
May 20, 2013
Q3
2012
Sep 30, 2012
$143.3K
Nov 19, 2012
Q2
2012
Jun 30, 2012
$71.7K
Sep 7, 2012
Q3
2013
Jun 30, 2012
$143.3K
Nov 19, 2013
Q1
2013
Mar 31, 2012
$159.5K
May 20, 2013
Q3
2011
Sep 30, 2011
$250.2K
Nov 21, 2011
Q2
2011
Jun 30, 2011
$0
Aug 16, 2011
Q2
2011
Jun 30, 2010
$0
Aug 16, 2011
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.73M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($6.26M)
Aug 8, 2025
Q1
2025
Mar 31, 2025
($4.89M)
May 12, 2025
Q3
2025
Sep 30, 2024
($4.75M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($2.32M)
Aug 8, 2025
Q1
2025
Mar 31, 2024
($2.51M)
May 12, 2025
Q3
2024
Sep 30, 2023
$2.15M
Nov 12, 2024
Q2
2024
Jun 30, 2023
($1.43M)
Aug 9, 2024
Q3
2023
Jun 30, 2023
($534.3K)
Nov 13, 2023
Q1
2024
Mar 31, 2023
($534.3K)
May 14, 2024
Q3
2023
Sep 30, 2022
($882.6K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($4.19M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($4.53M)
May 15, 2023
Q3
2022
Sep 30, 2021
($12.20M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($3.78M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($4.64M)
May 12, 2022
Q3
2021
Sep 30, 2020
($4.44M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($3.13M)
Aug 11, 2021
Q1
2021
Mar 31, 2020
($2.56M)
May 7, 2021
Q3
2020
Sep 30, 2019
($2.80M)
Nov 12, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.04M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($6.62M)
Aug 8, 2025
Q1
2025
Mar 31, 2025
($5.30M)
May 12, 2025
Q3
2025
Sep 30, 2024
($5.40M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($3.00M)
Aug 8, 2025
Q1
2025
Mar 31, 2024
($2.59M)
May 12, 2025
Q3
2024
Sep 30, 2023
($2.68M)
Nov 12, 2024
Q3
2023
Jun 30, 2023
($1.43M)
Nov 13, 2023
Q2
2024
Jun 30, 2023
($1.23M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($1.43M)
May 14, 2024
Q3
2023
Sep 30, 2022
($904.1K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($4.25M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($4.55M)
May 15, 2023
Q3
2022
Sep 30, 2021
($12.69M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($3.83M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($4.68M)
May 12, 2022
Q3
2021
Sep 30, 2020
($5.27M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($3.66M)
Aug 11, 2021
Q1
2021
Mar 31, 2020
$2.96M
May 7, 2021
Q3
2020
Sep 30, 2019
($3.05M)
Nov 12, 2020